QuitGenius, operating under the brand name Pelago, is a digital health startup that provides a virtual clinic for substance use care. The company offers personalized programs to help individuals manage and reduce their tobacco, alcohol, and opioid use. The service is designed to be cost-effective and accessible, aiming to remove the stigma often associated with traditional treatment programs.

The company's primary clients are organizations and health plans looking to reduce healthcare costs and improve the health and productivity of their workforce or members. The service is backed by extensive research and has shown promising results, with members reporting significant reductions in substance use within the first few months of care.

QuitGenius operates in the digital health market, specifically in the area of substance use treatment. The business model is based on providing its service to organizations and health plans, which in turn offer it to their employees or members. The company generates revenue through these B2B partnerships, charging for the use of its platform and services.

The startup's approach combines physician-led care teams, complex condition management, and personalized tech and support to provide a comprehensive solution for substance use management. The company prides itself on delivering life-changing outcomes that benefit both individuals and the organizations they are part of.

Keywords: Digital Health, Substance Use Treatment, Virtual Clinic, Personalized Care, Cost-Effective, Accessible, B2B Partnerships, Physician-Led Care, Complex Condition Management, Employee Health.